CCL2 and ovarian cancer: Regarding the upregulation of MCP-1/CCL2 in response to a high oxicam dose and longer exposure, the expression of MCP-1 has been shown to be upregulated several-fold in ovarian cancer by chemotherapy, and the effect has been reproducible at the mRNA and protein levels, both in vitro and in vivo [34].